PIERIS PHARMACEUTICALS, INC.·4

Mar 2, 4:02 PM ET

Yoder Stephen S. 4

4 · PIERIS PHARMACEUTICALS, INC. · Filed Mar 2, 2020

Insider Transaction Report

Form 4
Period: 2020-02-27
Yoder Stephen S.
DirectorCEO and President
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-02-27+420,000420,000 total
    Exercise: $3.15Exp: 2030-02-27Common Stock (420,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 25% of the option shares on February 27, 2021 and as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT